What's Hot

    The Future of Regulatory Technology: How RTOP and the Big 4 Are Shaping Compliance Trends

    September 12, 2023

    Elon Musk Flaunts Vast Competitive Edge — Auto Industry ‘Still Hasn’t Caught Up’ With Tesla From 10 Years Ago – Tesla (NASDAQ:TSLA)

    August 10, 2023

    Taylor Swift’s ‘Eras Tour’ Toronto Tickets Listed At $16K, Leaving Fans Aghast

    August 10, 2023
    Facebook Twitter Instagram YouTube LinkedIn TikTok Telegram
    Telegram
    InformatemiInformatemi
    Subscribe
    • Home
    • Blog
    • Contact
    InformatemiInformatemi
    Home»News»Cerevel Therapeutics Holdings (CERE) Shares Cross Above 200 DMA
    News

    Cerevel Therapeutics Holdings (CERE) Shares Cross Above 200 DMA

    BNK InvestBy BNK InvestApril 25, 2023Updated:April 25, 20231 Min Read
    Facebook Twitter LinkedIn Telegram Pinterest Tumblr Reddit WhatsApp Email
    Share
    Facebook Twitter LinkedIn Pinterest Email

    [ad_1]

    In trading on Monday, shares of Cerevel Therapeutics Holdings Inc (Symbol: CERE) crossed above their 200 day moving average of $28.85, changing hands as high as $29.50 per share. Cerevel Therapeutics Holdings Inc shares are currently trading up about 7.2% on the day. The chart below shows the one year performance of CERE shares, versus its 200 day moving average:


    Looking at the chart above, CERE’s low point in its 52 week range is $19.86 per share, with $41.46 as the 52 week high point — that compares with a last trade of $29.07.

    Click here to find out which 9 other stocks recently crossed above their 200 day moving average »

    Also see:

    • Top Stocks Held By Daniel Loeb
    • ASRT shares outstanding history
    • KMX Technical Analysis

    The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

    [ad_2]

    Source link

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
    Previous ArticlePutin’s Envoy Raises Concern Over ‘Steadily Growing’ Risks Of Nuclear War With US
    Next Article Apyx Medical (FRA:BOV) Price Target Decreased by 5.06% to 7.20
    BNK Invest

    Related Posts

    The Future of Regulatory Technology: How RTOP and the Big 4 Are Shaping Compliance Trends

    September 12, 2023

    Taylor Swift’s ‘Eras Tour’ Toronto Tickets Listed At $16K, Leaving Fans Aghast

    August 10, 2023

    Cs Disco (LAW) Q2 2023 Earnings Call Transcript

    August 10, 2023
    Top Posts

    The Future of Regulatory Technology: How RTOP and the Big 4 Are Shaping Compliance Trends

    September 12, 2023

    Taylor Swift’s ‘Eras Tour’ Toronto Tickets Listed At $16K, Leaving Fans Aghast

    August 10, 2023

    Cs Disco (LAW) Q2 2023 Earnings Call Transcript

    August 10, 2023

    Subscribe to Updates

    Discover hidden stock market gems and stay up to date with our weekly email newsletter and individual stock ideas

    [wpforms id="4157" title="false"]

    Gain access to our Newsletter, SMS Alerts, and Telegram Community for FREE

    Top Insights

    The Future of Regulatory Technology: How RTOP and the Big 4 Are Shaping Compliance Trends

    September 12, 2023

    Elon Musk Flaunts Vast Competitive Edge — Auto Industry ‘Still Hasn’t Caught Up’ With Tesla From 10 Years Ago – Tesla (NASDAQ:TSLA)

    August 10, 2023

    Taylor Swift’s ‘Eras Tour’ Toronto Tickets Listed At $16K, Leaving Fans Aghast

    August 10, 2023
    Get Informed

    Subscribe to Updates

    Discover hidden stock market gems and stay up to date with our weekly email newsletter and individual stock ideas

    [wpforms id="4157" title="false"]
    Facebook Twitter Instagram YouTube LinkedIn TikTok
    • Privacy Policy
    • Disclaimer
    • SMS Squeeze
    • Sign Up
    © 2023 Informatemi

    Type above and press Enter to search. Press Esc to cancel.